2013
DOI: 10.1074/jbc.m113.455816
|View full text |Cite
|
Sign up to set email alerts
|

EP2 Receptor Signaling Pathways Regulate Classical Activation of Microglia

Abstract: Background: Microglial activation contributes strongly to brain inflammation. Results: The modulation of microglial cyclooxygenase-2, iNOS, and cytokine production by EP2 (PTGER2) activation is not blocked by a protein kinase A antagonist but is mimicked by an Epac agonist. Conclusion: Epac signaling pathways prominently contribute to the modulation of microglial activation by EP2. Significance: EP2 and Epac represent potential immunomodulatory targets during brain inflammation.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

9
96
2

Year Published

2015
2015
2020
2020

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 92 publications
(107 citation statements)
references
References 59 publications
9
96
2
Order By: Relevance
“…8 In contrast, EP2 receptor signaling protects cultured neurons under various conditions through the cAMP/PKA or cAMP/Epac pathway [9][10][11][12] and regulates microglial activation and function in vitro. [13][14][15][16] These findings reflect cell-specific differences in EP2 signaling. In vivo work has shown that the EP2 receptor has beneficial effects in models of ischemic stroke 12,17,18 but detrimental effects in models of Alzheimer's disease, 19,20 Parkinson's disease, 21 and amyotrophic lateral sclerosis.…”
Section: Introductionmentioning
confidence: 87%
See 1 more Smart Citation
“…8 In contrast, EP2 receptor signaling protects cultured neurons under various conditions through the cAMP/PKA or cAMP/Epac pathway [9][10][11][12] and regulates microglial activation and function in vitro. [13][14][15][16] These findings reflect cell-specific differences in EP2 signaling. In vivo work has shown that the EP2 receptor has beneficial effects in models of ischemic stroke 12,17,18 but detrimental effects in models of Alzheimer's disease, 19,20 Parkinson's disease, 21 and amyotrophic lateral sclerosis.…”
Section: Introductionmentioning
confidence: 87%
“…12,41 Neuronal EP2 signaling has been shown to be protective in in vitro and in vivo models of cerebral ischemia. 11,16,17 Interestingly, in vitro studies have shown that activation of the EP2 receptor also regulates microglial activation and function, [13][14][15][16] which implies a detrimental role in chronic neuropathologic conditions such as Alzheimer's disease, 19,20 Parkinson's disease, 21 and amyotrophic lateral sclerosis. 22 In mice that underwent collagenase-induced ICH, EP2 receptors were expressed primarily in striatal neurons.…”
Section: Discussionmentioning
confidence: 99%
“…One possibility is that neuron-released prostaglandin E 2 , a product of cyclooxygenase-2 (COX-2), induces microglial CCL2 expression via EP2 receptors. Indeed, genetic removal of neuronal COX-2 or EP2 antagonism can mitigate the induction of CCL2 mRNA in the brain (6,8,9) or in purified microglia (57). Another possibility is that neuronal ATP release increases CCL2 in microglia via P2X7 receptors (58).…”
Section: Discussionmentioning
confidence: 99%
“…Con, control group; PGE2, prostaglandin E2; PD-1, programmed cell death-1; CD, cluster of differentiation. EP1 is reported to be associated with intracellular calcium concentration, and promoter analysis of the EP2 and EP4 genes indicated the presence of several consensus sequences associated with inflammatory stimuli, including interleukin-6, nuclear factor-κB and activator protein 2 (29,30). A previous study revealed that EP4 is able to mediate PGE2-induced migration of A549 lung cancer cells (31).…”
Section: Discussionmentioning
confidence: 99%